Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment (NCT07225400)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this one-arm clinical trial is to determine whether participants with mild cognitive impairment (MCI) can successfully navigate a virtual reality (VR) maze. The VR maze is designed as a training tool aimed at improving participants' spatial navigation abilities. Main Aims: 1. To determine whether at least 70% of older adults enrolled in the study can complete twenty-four 50-minute training sessions over a 4-month period. 2. To assess whether combining virtual reality with EEG recordings can be used to measure brain activation and changes in brain activation associated with spatial navigation learning. Participants will: 1. Walk in an open, unobstructed space while wearing VR goggles. 2. Explore up to fifty different virtual mazes in sequence and attempt to find their way through each one.
Who can join: Review the eligibility criteria below.
Location: Albert Einstein College of Medicine — The Bronx, New York
Age range: 65 Years
🧪 Interventions in This Study
- Spatial Navigation training (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Albert Einstein College of Medicine — The Bronx, New York
📞 Contact the Study Coordinator
Phone: (718) 862-1828
Email: pierfilippo.sanctis@einsteinmed.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Mild Cognitive Impairment (MCI)
- Wearable Sensor for Early Detection and Monitoring of Cognitive Decline — Los Angeles, California
- Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers — La Jolla, California
- AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults — Boston, Massachusetts
- Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity — Augusta, Georgia
- An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) — Saint Paul, Minnesota
- Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. — Palisades Park, New Jersey
Explore by condition: All Mild Cognitive Impairment (MCI) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.